Journey Medical (DERM) Metrics: History & Chart

Journey Medical Corporation(DERM)

Drug Manufacturers - Specialty & Generic · Scottsdale, AZ

$6.50-0.19 (-2.80%)

Delayed quote: Oct 6, 2026, 12:10 PM EDT

About Journey Medical Corporation

Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.

Scottsdale, AZ

58 employees

journeymedicalcorp.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Claude Maraoui

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+4.04%
30D Total Return	-14.89%
YTD Total Return	-13.23%
1Y Total Return	-8.73%
3Y Total Return	+138.08%
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-13.23%
2025	+97.19%
2024	-32.12%
2023	+200.00%
2022	-64.31%
2021	N/A

CAGR TTM	-8.69%
CAGR 3Y	+33.52%
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

DERM Valuation Metrics

DERM Stock Price Metrics

DERM Dividend Metrics

DERM Growth Rate Metrics

DERM Discounted Cash Flow Metrics

DERM Returns By Period

DERM Yearly Returns

DERM Average Annual Returns By Period (CAGR)

DERM Revenue Metrics

DERM PE Ratio Metrics

DERM PS Ratio Metrics

DERM PB Ratio Metrics

DERM Price to Free Cash Flow Ratio Metrics

DERM Debt to Equity Ratio Metrics

DERM PEG Ratio Metrics

DERM FCF Yield

DERM Earnings Yield

DERM EBITDA Yield

DERM OCF Yield

DERM EV/EBIT Ratio Metrics

DERM EV/EBITDA Ratio Metrics

DERM EV/Assets Ratio Metrics

DERM EV/Sales Ratio Metrics

DERM Current Ratio Metrics

DERM Quick Ratio Metrics

DERM ROIC Metrics

DERM Return on Assets Metrics

DERM Return on Equity Metrics

DERM Net Profit Margin Metrics

DERM Gross Profit Margin Metrics

DERM Tax Rate Metrics

PS Ratio	2.70
PS Ratio Avg TTM	2.93
PS Ratio Avg 3Y	2.14
Current VS TTM Avg	-7.90%
Current VS 3Y Avg	+26.30%
Current VS 5Y Avg	+71.89%

PB Ratio	5.73
PB Ratio Avg TTM	6.60
PB Ratio Avg 3Y	7.28
Current VS TTM Avg	-13.23%
Current VS 3Y Avg	-21.30%
Current VS 5Y Avg	+3.38%

PFCF Ratio	70.84
PFCF Ratio Avg TTM	37.25
PFCF Ratio Avg 3Y	28.20
Current VS TTM Avg	+90.20%
Current VS 3Y Avg	+151.20%
Current VS 5Y Avg	+151.20%

Debt/Equity Ratio	0.80
Debt/Equity Ratio Avg TTM	0.94
Debt/Equity Ratio Avg 3Y	1.13
Current VS TTM Avg	-15.55%
Current VS 3Y Avg	-29.46%
Current VS 5Y Avg	-21.34%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	1.41%
FCF Yield Avg TTM	7.28%
FCF Yield Avg 3Y	8.72%
Current VS TTM Avg	-80.63%
Current VS 3Y Avg	-83.82%
Current VS 5Y Avg	-83.82%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	50.78
Ev/Ebit Ratio Avg TTM	50.33
Ev/Ebit Ratio Avg 3Y	50.33
Current VS TTM Avg	+0.90%
Current VS 3Y Avg	+0.90%
Current VS 5Y Avg	+0.90%

Ev/Ebitda Ratio	145.67
Ev/Ebitda Ratio Avg TTM	155.63
Ev/Ebitda Ratio Avg 3Y	70.41
Current VS TTM Avg	-6.40%
Current VS 3Y Avg	+106.90%
Current VS 5Y Avg	+106.90%

Ev/Assets Ratio	1.87
Ev/Assets Ratio Avg TTM	2.05
Ev/Assets Ratio Avg 3Y	1.69
Current VS TTM Avg	-8.56%
Current VS 3Y Avg	+10.71%
Current VS 5Y Avg	+56.50%

Ev/Sales Ratio	2.70
Ev/Sales Ratio Avg TTM	2.94
Ev/Sales Ratio Avg 3Y	2.11
Current VS TTM Avg	-8.14%
Current VS 3Y Avg	+28.06%
Current VS 5Y Avg	+77.21%

Current Ratio	1.59
Current Ratio Avg TTM	1.56
Current Ratio Avg 3Y	1.37
Current VS TTM Avg	+2.20%
Current VS 3Y Avg	+16.45%
Current VS 5Y Avg	+18.10%

Quick Ratio	1.41
Quick Ratio Avg TTM	1.30
Quick Ratio Avg 3Y	0.99
Current VS TTM Avg	+8.88%
Current VS 3Y Avg	+42.70%
Current VS 5Y Avg	+37.12%

ROIC	(5.22%)
ROIC Avg 3Y	(18.00%)
ROIC Avg 5Y	(35.92%)
Current VS 3Y Avg	+71.01%
Current VS 5Y Avg	+85.48%
Current VS 10Y Avg	+87.05%

ROA	(6.21%)
ROA Avg TTM	(2.29%)
ROA Avg 3Y	(2.60%)
Current VS TTM Avg	-170.79%
Current VS 3Y Avg	-138.47%
Current VS 5Y Avg	+12.62%

ROE	(19.01%)
ROE Avg TTM	(32.97%)
ROE Avg 3Y	(35.56%)
Current VS TTM Avg	+42.34%
Current VS 3Y Avg	+46.54%
Current VS 5Y Avg	+73.57%

Net Profit Margin	(8.95%)
Net Profit Margin Avg TTM	(12.37%)
Net Profit Margin Avg 3Y	(16.67%)
Current VS TTM Avg	+27.63%
Current VS 3Y Avg	+46.31%
Current VS 5Y Avg	+74.26%

Gross Profit Margin	62.24%
Gross Pft Margin Avg TTM	61.54%
Gross Pft Margin Avg 3Y	62.38%
Current VS TTM Avg	+1.14%
Current VS 3Y Avg	-0.23%
Current VS 5Y Avg	+7.59%

Tax Rate	3.86%
Tax Rate Avg 3Y	2.21%
Tax Rate Avg 5Y	27.75%
Current VS 3Y Avg	+74.53%
Current VS 5Y Avg	-86.10%
Current VS 10Y Avg	-86.10%